IINB vs. QLB for Elective Open Inguinal Herniorrhaphy

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 30, 2017

Primary Completion Date

February 17, 2018

Study Completion Date

February 17, 2018

Conditions
Nerve BlockHerniorrhaphyRegional Anesthesia
Interventions
PROCEDURE

Ilioinguinal / Iliohypogastric Block

Patients randomized to this arm will receive 25cc's of Bupivacaine 0.25% + Epinephrine 1:200k + Clonidine 1.66mcg/cc administered via an ultrasound guided ilioinguinal / iliohypogastric block technique.

PROCEDURE

Quadratus Lumborum Block

Patients randomized to this arm will receive 25cc's of Bupivacaine 0.25% + Epinephrine 1:200k + Clonidine 1.66mcg/cc administered via an ultrasound guided quadratus lumborum block technique.

DRUG

Bupivacaine 0.25%

Administered as part of the local anesthetic mixture

DRUG

Epinephrine 1:200k

Administered as part of the local anesthetic mixture

DRUG

Clonidine 1.66mcg/cc

Administered as part of the local anesthetic mixture

Trial Locations (1)

27157

Wake Forest Baptist Medical Center, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03007966 - IINB vs. QLB for Elective Open Inguinal Herniorrhaphy | Biotech Hunter | Biotech Hunter